JDRF Blog

JDRF Blog

Information on research, events, activities, and news from the T1D community across Canada. 

Subscribe to the newsletter

Monsters are real

JDRF Canada has a plan to defeat the T1D monster that burdens 300,000 Canadians.

Read More

Advancing cell replacement therapies to treat more people with type 1 diabetes

Advancing cell replacement therapies to treat more people with type 1 diabetes

Dr. Pepper is a promising young Canadian scientist and a new assistant professor in the Department of Surgery at the University of Alberta.


#AccessForAll in the age of COVID-19

#AccessForAll in the age of COVID-19

As COVID-19 continues to dominate global headlines, the journey to #AccessForAll remains.


Advocating for insulin pumps in Manitoba

Advocating for insulin pumps in Manitoba

JDRF’s message to the government was straightforward and simple: Manitobans with type 1 diabetes at all ages need access to insulin pumps. 


Using your voice to fight against type 1 diabetes

Using your voice to fight against type 1 diabetes

At JDRF, we know that when it comes to fighting against type 1 diabetes (T1D), there is strength in numbers.


I have type 1 diabetes (T1D) and am worried I'll have to go into the hospital during the COVID-19 outbreak. How can I prepare?

I have type 1 diabetes (T1D) and am worried I'll have to go into the hospital during the COVID-19 outbreak. How can I prepare?

 Below are a few tips to help you better cope in case a hospital visit is required.


Talking to an expert on T1D and COVID-19

Talking to an expert on T1D and COVID-19

A Q & A with Dr. Rémi Rabasa-Lhoret, JDRF-funded clinical scientist and endocrinologist at the Institut de recherches cliniques de Montréal


Type 1 diabetes (T1D) and COVID-19: Frequently Asked Questions

Type 1 diabetes (T1D) and COVID-19: Frequently Asked Questions

JDRF Canada consulted a panel of Canadian endocrinologists to provide answers to some of your most frequently asked questions.


A letter to the T1D community from JDRF President and CEO Dave Prowten

A letter to the T1D community from JDRF President and CEO Dave Prowten

I have been blown away by the strength, resilience and generosity demonstrated by you, our JDRF family. I am reminded of how privileged we are to have your continued support. 


Severe lows? Spray it in the nose! New Nasal Glucagon for severe hypoglycemia available in Canada!

Novel dual-hormone artificial pancreas offers hope for better management of T1D

Novel dual-hormone insulin therapy offers hope for better management of type 1 diabetes

Drs. Ahmad Haidar, Laurent Legault, Michael Tsoukas and Jean-Franҫois Yale are a team of JDRF-funded researchers at McGill University (Montreal) who are the first to test the addition of pramlintide (a synthetic form of amylin, which is a hormone co-secreted with insulin by the healthy pancreas) to ...


Lets turn type one into type none